United Therapeutics Corporation UTHR
601.32 USD +5.19 (+0.87%)
At closeNov 3, 2026, 4:00 PM EST
605.67 +4.35 +0.72%
After hours · Nov 3, 4:00 PM ET
596.14 Day range 606.16
430.02 52-week range 609.99
- YTD
- +23.41%
- 1 year
- +37.08%
Held by funds
335 US ETFs and mutual funds hold UTHR · largest positions
Ownership
Held by insiders 2.00%
Held by institutions 100.44%
Float held by institutions 102.49%
Institutions 1,228
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 12.34% | 5,294,529 | 3.18B | Jun 29, 2026 |
| Avoro Capital Advisors LLC | 6.48% | 2,777,777 | 1.67B | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 4.48% | 1,919,429 | 1.15B | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.47% | 1,918,256 | 1.15B | Jun 29, 2026 |
| State Street Corporation | 4.43% | 1,898,064 | 1.14B | Jun 29, 2026 |
| Renaissance Technologies, LLC | 3.98% | 1,708,739 | 1.03B | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.56% | 1,527,799 | 918.70M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.14% | 1,347,720 | 810.41M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.27% | 973,490 | 585.38M | Jun 29, 2026 |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 1.68% | 719,385 | 432.58M | Jul 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.13% | 486,555 | 292.58M | Jun 29, 2026 |
| iShares Trust-iShares Biotechnology ETF | 0.75% | 323,432 | 194.49M | Sep 29, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BENKOWITZ MICHAEL | President | Conversion of Exercise of derivative security | Mar 12, 2026 | 0 |
| CAUSEY CHRISTOPHER | Director | Sale | Mar 29, 2026 | 4,190 |
| EDGEMOND JAMES C. | Chief Financial Officer | Conversion of Exercise of derivative security | Jun 21, 2026 | 18,876 |
| GILTNER RICHARD A | Director | Conversion of Exercise of derivative security | Jul 8, 2026 | 21,884 |
| KURZWEIL RAYMOND C | Director | Conversion of Exercise of derivative security | Jul 8, 2026 | 13,320 |
| MAHON PAUL A | General Counsel | Sale | Sep 30, 2026 | 45,172 |
